Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2020)10.1016/j.bbcan.2020.188383Source: DataRank Database

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients is a research paper published in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 4.13)OA: greenTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Lei Xi ORCID,Kaustubh Datta ORCID,Anindita Das ORCID,Benjamin A. Teply ORCID,Surinder K. Batra ORCID

Live enrichment

PubMed:32535158 PMC:PMC7473503 OpenAlex:https://openalex.org/W3035633760

National Cancer Institute

Grant: UO1 CA185148

National Institutes of Health

Grant: DK120866

National Institutes of Health

Grant: RO1 CA221813

National Institutes of Health

Grant: HL118808

National Institutes of Health

Grant: RO1 HL134366

U.S. Department of Defense

Grant: PC170891

U.S. Department of Defense

Grant: W81XWH-18-1-0308

NCI NIH HHS

Grant: U01 CA185148

NHLBI NIH HHS

Grant: R01 HL118808

NIDDK NIH HHS

Grant: R01 DK120866

NCI NIH HHS

Grant: R01 CA221813

NHLBI NIH HHS

Grant: R01 HL134366

National Cancer Institute

National Institutes of Health

U.S. Department of Defense

FWCI

4.13

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7473503

publisherhttps://api.elsevier.com/content/article/PII:S0304419X20301025?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304419X20301025?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bbcan.2020.188383

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationProstate Cancer Treatment and ResearchCardiac Imaging and DiagnosticsAndrogen AntagonistsAndrogensAntineoplastic Agents, HormonalCardiotoxicityCardiovascular DiseasesClinical Trials as TopicCyclic GMPGonadotropin-Releasing HormoneHumansLongevityMaleObservational Studies as TopicPhosphodiesterase 5 InhibitorsProstatic NeoplasmsReceptors, LHRHRisk FactorsSignal TransductionTime FactorsTreatment Outcome

MeSH Terms

Androgen AntagonistsAndrogensCardiovascular DiseasesClinical Trials as TopicCyclic GMPHumansGonadotropin-Releasing HormoneLongevityMaleProstatic NeoplasmsReceptors, LHRHRisk FactorsTime FactorsSignal TransductionTreatment OutcomeAntineoplastic Agents, HormonalPhosphodiesterase 5 InhibitorsObservational Studies as TopicCardiotoxicity

Keywords

CardiotoxicityMedicineProstate cancerAndrogen deprivation therapyOncologyAdverse effectInternal medicineAndrogen receptorClinical trialCancerBioinformaticsChemotherapycGMPSildenafil citrateGnrh Agonists

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients

FAIR Checklist

Authors (7)

Funding (15 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)